These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36744531)

  • 1. Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen.
    Regidor PA; Mueller A; Mayr M
    Womens Health (Lond); 2023; 19():17455057221147388. PubMed ID: 36744531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone.
    Morimont L; Jost M; Gaspard U; Foidart JM; Dogné JM; Douxfils J
    J Clin Endocrinol Metab; 2022 Dec; 108(1):135-143. PubMed ID: 36099501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters.
    Douxfils J; Klipping C; Duijkers I; Kinet V; Mawet M; Maillard C; Jost M; Rosing J; Foidart JM
    Contraception; 2020 Dec; 102(6):396-402. PubMed ID: 32956694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estetrol and the possibilities of its clinical use.
    Křepelka Petr
    Ceska Gynekol; 2021; 86(3):217-221. PubMed ID: 34167315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives.
    Mawet M; Maillard C; Klipping C; Zimmerman Y; Foidart JM; Coelingh Bennink HJ
    Eur J Contracept Reprod Health Care; 2015; 20(6):463-75. PubMed ID: 26212489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function.
    Duijkers I; Klipping C; Kinet V; Jost M; Bastidas A; Foidart JM
    Contraception; 2021 Jun; 103(6):386-393. PubMed ID: 33689786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone.
    Klipping C; Duijkers I; Mawet M; Maillard C; Bastidas A; Jost M; Foidart JM
    Contraception; 2021 Apr; 103(4):213-221. PubMed ID: 33428907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of different progestogens: the special case of drospirenone.
    Sitruk-Ware R
    Climacteric; 2005 Oct; 8 Suppl 3():4-12. PubMed ID: 16203650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
    Oelkers WH
    Climacteric; 2005 Oct; 8 Suppl 3():19-27. PubMed ID: 16203652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation.
    Bastianelli C; Farris M; Rosato E; Brosens I; Benagiano G
    Expert Rev Clin Pharmacol; 2018 Nov; 11(11):1085-1098. PubMed ID: 30325245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estetrol/Drospirenone: A Review in Oral Contraception.
    Lee A; Syed YY
    Drugs; 2022 Jul; 82(10):1117-1125. PubMed ID: 35781795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers.
    Oelkers W; Helmerhorst FM; Wuttke W; Heithecker R
    Gynecol Endocrinol; 2000 Jun; 14(3):204-13. PubMed ID: 10923282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study.
    Duijkers IJ; Klipping C; Zimmerman Y; Appels N; Jost M; Maillard C; Mawet M; Foidart JM; Coelingh Bennink HJ
    Eur J Contracept Reprod Health Care; 2015; 20(6):476-89. PubMed ID: 26394847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women.
    Giribela CR; Consolim-Colombo FM; Nisenbaum MG; Moraes TL; Giribela AH; Baracat EC; Melo NR
    Gynecol Endocrinol; 2015; 31(11):912-5. PubMed ID: 26172927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis.
    Farris M; Bastianelli C; Rosato E; Brosens I; Benagiano G
    Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1129-1144. PubMed ID: 28712325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris.
    Fenton C; Wellington K; Moen MD; Robinson DM
    Drugs; 2007; 67(12):1749-65. PubMed ID: 17683173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Added benefits of drospirenone for compliance.
    Foidart JM
    Climacteric; 2005 Oct; 8 Suppl 3():28-34. PubMed ID: 16203653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioequivalence study of an oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium relative to ethinylestradiol/drospirenone and to levomefolate calcium alone.
    Blode H; Klipping C; Richard F; Trummer D; Rohde B; Diefenbach K
    Contraception; 2012 Feb; 85(2):177-84. PubMed ID: 22067789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.